COVID-19

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

As the world grasps the severity of the ongoing pandemic, we must ask how we can accelerate vaccine development safely.

It is well accepted that vaccine development needs to move faster, but how can companies balance compliance and speed?

How are counterfeiters exploiting the COVID-19 pandemic to make a profit?

How is the business of making medicine changing in light of the COVID-19 pandemic?

What role can CMOs play in the fight against fakes?

How are counterfeiters taking advantage of the COVID-19 pandemic?

Llama antibodies may be crucial in the fight against COVID-19.

An AI platform seeks out drugs that can be repurposed to treat COVID-19.

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.